Skip to main content
. Author manuscript; available in PMC: 2009 Dec 15.
Published in final edited form as: J Neurol Sci. 2008 Sep 9;275(1-2):106–112. doi: 10.1016/j.jns.2008.07.032

Table 2.

CSF and serum concentrations of glucose and metabolites

Variablea Subject group
HC
N=18		 RR
N=31		 SP
N=54		 Analysis
Glucose
CSF (mM)		 3.24 ± 0.36 3.46 ± 0.48 3.51 ± 0.78 F=1.32, df=2, 100, p=0.271
Glucose
Serum (mM)		 4.58 ± 0.48 4.54 ± 1.0 4.31 ± 0.99 F=0.87, df=2, 100, p=0.422
Lactate
CSF (mM)		 1.31 ± 0.19 1.55 ± 0.30 1.67 ± 0.29 F=11.2, df=2, 100, p<0.001
SP>HC (p<0.001)
RR>HC (p=0.005)
Sorbitol
CSF (μM)		 15.6 ± 3.9 22.0 ± 3.7 23.4 ± 9.4 F=14.0, df=2, 100, p=0.001
SP>HC (p<0.001)
RR>HC (p<0.001)
Fructose
CSF (μM)		 156 ± 50 209 ± 85 227 ± 87 F=5.27, df=2, 100, p=0.007
SP>HC (p<0.001)
RR>HC (p=0.017)
Myoinositol
CSF (μM)		 150 ± 29 178 ± 42 165 ± 43 F=2.72, df=2, 100, p=0.070
F=1.77, df=2, 63, p=0.179b

HC=Healthy Controls, RR MS=Relapsing-remitting MS patients, SP MS=Secondary progressive MS patients, WBC=white blood cell.

a

Values are means ± standard deviation.

b

ANCOVA with CSF WBC count as covariate.